Transaction · 0001193125-26-407937

Leoni Mollie

Leoni Mollie, CMO, reported an open-market or private sale at Kura Oncology, Inc. involving 28802.000000 shares for an estimated $309566.78. Reported holdings after the transaction were 141095.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCMO
KURAKura Oncology, Inc.
Filing timeSep 29
Trade dateSep 29, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded16.95%Shares sold ÷ (holdings after + shares sold). Estimated position before: 169,897 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$10.80
Pre-filing
1mo ago +17.2%1w ago +8.6%1d ago -1.8%
Returns since
7d30d90d180d1y

KURA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
KURA since 2026-09-29Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-407937
Common Stock
Transaction date
Sep 29, 2026
Filed Sep 29, 2026, 10:30 PM · 0d delay
Shares
28.8k sh
$10.75 per share
Estimated value
-$309k
Computed from shares × price
Holdings after
141k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU re…

  2. F2

    The shares sold were acquired by the Reporting Person upon vesting of performance restricted stock units on September 27, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 tradin…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $10.53 to $10.89. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to p…

Original filing · 0001193125-26-407937
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

KURA